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3ABSTRACT
An evaluation of a triage system set up in response to the NHS Executive requirement for 
audit, discussion of outcomes and limitations.
INTRODUCTION
In 1989 the NHS Executive made clinical audit a requirement for clinical professions 
including clinical psychology (DoH, 1989). Subsequent documents have expanded this to 
include a discussion of clinical governance and quality initiatives (DoH, 1997). Clinical 
audit has been recognised as one of the main elements of quality initiatives (Dickens, 
1994). The DCP working group has responded by proposing that all psychologists should 
be involved in the audit process by evaluating and improving their practice (Cape, 1995).
However, despite encouragement from both the government (DoH, 1989) and the Division 
of Clinical Psychology, (Cape, 1995), there seems to be a reluctance on the part of 
psychologists to become involved in clinical audit. This could be a result of the fear of 
detecting the need for change either as a result of the intervention being ineffective or as a 
result of the therapist’s inability to bring about change (Halstead, 1996). Furthermore, 
clinical audit is often perceived to be a time consuming endeavour (Halstead, 1996). As a 
result of this it is often neglected in favour of increasing patient caseloads and developing 
new initiatives for managing patient waiting lists. This is despite evidence indicating that 
time spent in audit of services may result in service development (Paxton, 1995) by 
impacting on waiting lists and efficiency. Paxton (1995) further suggests that clinical audit
may feasibly represent an active link between the two main roles inherent in the scientist 
practitioner model that is a fundamental part of the profession.
Consulting and Clinical Psychology Services (CCPS) is a multidisciplinary sendee that 
operates with a skill mix of clinical psychologists and other professions, including 
counselling psychologists, CBT nurse specialists and counsellors. This service was set up 
in response to the Mowbray report (Management Advisory Service, 1989) which 
highlighted the fact that psychological skills were no longer solely the domain o f clinical 
psychologists. The report described a three level framework of psychological skill with 
level 1 as basic psychological activities, level 2 as circumscribed psychological activities 
and level 3 as specialist psychological intervention. The report notes that clinical 
psychologists are able to work at all three levels. * *
With an ongoing shortage of clinical psychologists it is important to recognise the role 
other professions have in the provision of psychological services. This skill mix allows 
range, effectiveness and cost-efficiency to be maximised without any loss to the quality of 
the service (SCPMDE, 1999). It allows the service to make the best use of the specialist 
expertise of clinical psychologists by allowing the majority of their time to be spent 
working with cases that require level 3 skills. However, establishing the complexity of a 
case to allow allocation to the appropriate discipline proved difficult based only on the 
referral letter. In response, a triage system was set up to provide an initial assessment 
carried out by a clinical psychologist, enabling appropriate allocation. The triage system 
also aimed to provide a system that would allow the prioritisation of need and possibly 
reduce waiting times by filtering out inappropriate referrals.
5Referrals to CCPS are received and placed on a primary waiting list. The service aims to 
see all patients for an initial assessment within nine weeks of referral. An appointment for 
an initial assessment is sent out which includes an opt-in system. It had been recognised 
that 17% of outpatients fail to attend their first appointment (Madden and Hinks, 1987) 
which wastes the time of clinicians and as a result impacts on the waiting list. Opt-in 
systems are considered an effective method of reducing this problem (Startup, 1994). 
Patients are asked to fill-in and return a tear-off slip indicating if they are going to attend 
their appointment. They are given a retum-by date. If the patient indicates they do not 
wish a further appointment or does not return their acceptance they are discharged at this 
point.
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Assessment clinics are held by 11 psychologists in 12 locations, covering both north and 
south Ayrshire. Patients whose referral is inappropriate are discharged following their 
initial assessment and referred to an alternative service if this is required. Appropriate 
referrals are allocated to a secondary waiting list to await treatment and recommendation of 
the profession that works at the most appropriate level for their difficulties is made.
The new triage system also presented the CCPS with an opportunity to look at audit of the 
service. A database was set up using information recorded at the initial assessment 
appointment.
One year on, there is now a suitable quantity of data to allow an audit of the service to be 
carried out. The aims of this audit were to:
6•improve our understanding of the characteristics of the client population 
•provide information regarding type and source of referral 
•provide data to guide future developments in service provision 
•provide information regarding the suitability of the system as an audit tool
The information for the database used in this study is only collected at the initial triage 
assessment. The scope of the study is therefore limited to information available at that 
time.
METHOD
There were 714 participants included in this audit. This was all the patients *Mio were 
referred to and assessed as part of the triage system between the period of 1 May 1999 and 
30 April 2000. Those who opted-out or Did Not Attend (DNA) on first appointment were 
not included in the sample as none of this data were collected.
Data were collected throughout the year by the assessing psychologists and were entered 
into the computer by an assistant psychologist. The data for the period 1 May 1999 - 30 
September 1999 were collated on Access and the period of 1 October 1999 - 30 April 2000 
were collated on SPSS. In order to carry out data analysis the data on Access were 
transferred to the SPSS database.
The information was gathered, by the assessing psychologist, using a proforma (Appendix 
1.2) and included the following information:
• DOB
• gender
• referral date
• referring agency
• assessment date
• presenting problem/s
• contributing factor/s
• problem category
• allocation to secondary waiting list
• priority on waiting list
• refer out-with CCPS
• type of intervention required
• individual or group intervention
The data from these variables were analysed using descriptive statistics. Individual anxiety 
and mood disorders were specified on the database. However, for purposes of analysis 
these disorders were combined into two categories, anxiety disorders and mood disorders as 
classified by DSM-IV (APA, 1994).
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Descriptive data 
Demographics
Of the 714 participants, 421 (59%) were female, 292 (40.9%) were male and there was one 
data point missing. The age distribution of those attending was as follows:
Table 1: Gender distribution according to age
Male
Frequency
Male
Percentage
Female Frequency Female Percentage Overall Percentage
1 6 -2 0 23 3.2 29 4.1 7.3
2 1 -3 0 71 9.9 105 14.8 24.7
31 -4 0 90 12.7 113 15.8 28.5
4 1 - 5 0 51 7.1 84 11.8 18.9
51 + 52 7.3 79 11.1 18.4
The table shows the percentages o f male and female referrals falling into each age band.
There were 16 (2.2%) data points missing from this group.
Time to first appointment
The average waiting time from referral to triage assessment appointment was 10.39 weeks 
(SD 7.21).
9So urce o f referral
Figure 1: Source of referral
□  GP’s
□  Psychiatry
□  CMHT
□  Other 
■  Missing
The figure shows percentage o f referrals from each source.
Five hundred and thirty five (74.9%) referral’s were received from G P’s, 81 (11.3%) 
referral’s from psychiatry, 66 (9.2%) from CMFIT’s, and 26 (3.7%) from other sources. 
There were 5 cases missing from the database. CMHT referrals are received from both 
psychiatry and CPN’s.
Presenting problem
Table 2: Primary and Secondary Presenting Problem
Primary
Frequency
Primary
Percentage
Secondary
Frequency
Secondary
Percentage
Anger 49 6.9 26 3.6
Anorexia 3 0.4 0 0
Anti-Social 2 0.3 2 0.3
Anxiety disorder 239 33.5 127 17.8
Attention deficit 1 0.1 0 0
Bulimia 0 0 1 0.1
Carer management 2 0.3 0 0
Communication 1 0.1 2 0.3
Encopresis 1 0.1 1 0.1
Family problems 4 0.6 6 0.8
Gambling 1 0.1 0 0
Grief reaction 11 1.5 7 1.0
Hypersomnia 2 0.3 0 0
Illness behaviour 11 1.5 3 0.4
Immature 2 0.3 0 0
Insomnia 5 0.7 2 0.3
Intellectual/memory impairment 21 2.9 1 0.1
Interpersonal skills 1 0.1 2 0.3
Irritability 0 0 3 0.4
Marital problems 14 2.0 14 2.0
Mood disorder 172 24.1 78 10.9
Motivation 0 0 1 0.1
Not otherwise specified 42 5.9 16 2.2
Obsessional 8 1.1 5 0.7
Over-eating 3 0.4 1 0.1
Pain 6 0.8 3 0.4
Parental management 1 0.1 1 0.1
Peer relationships 6 0.8 2 0.3
Perceptual deficits 1 0.1 0 0
Psychosexual dysfunction 7 1.0 2 0.3
Ruminations 2 0.3 3 0.4
Schizoid 1 0.1 1 0.1
Self injury 1 0.1 1 0.1
Separation anxiety 2 0.3 1 0.1
Sexual identity 0 0 2 0.3
Social relationship 7 1.0 9 1.3
Social withdrawal 0 0 3 0.4
Stereotypy 0 0 1 0.1
Stress adjustment 37 5.2 37 5.2
Substance use - alcohol 10 1.4 7 1.0
Substance use - drugs 2 0.3 5 0.7
Temper tantrums 4 0.6 2 0.3
Work stress 13 1.8 10 1.4
Missing data 19 2.6 319 44.6
The table show the number o f primary and secondary presenting problems by 
problem category.
Anxiety and mood disorders accounted for the largest number of referrals. Two hundred 
and thirty-nine (33.5%) of the referrals had an anxiety disorder as the primary presenting 
problem and a further 127 (17.8%) referrals had an anxiety disorder identified as the
secondary presenting problem. Mood disorders accounted for 172 (24.1%) of the primary 
presenting problems, with a further 78 (10.9%) as a secondary problem. Other disorders 
that presented in fairly large numbers included anger management (49, 6.9%) and stress 
adjustment (37, 5.2%).
Allocation to secondary waiting list
Table 3: Discharges following initial assessment
Frequency Percentage
Difficulty resolved prior to appointment 14 19.2
Single session sufficient 30 41.1
Other 29 39.7
Total 73 100
The table shows the number o f referrals discharged following initial 
assessment and the reason for this discharge.
Seventy three (10.2%) of the participants were not offered further appointments within the 
CCPS. Fourteen of these indicated that their difficulties had been resolved prior to their 
appointment date. Thirty felt that a single session had been sufficient to alleviate their 
problems and a further 29 were discharged for a variety of other reasons. However, due to 
the limitations of the database these are not accessible.
Table 4: Priority allocation on secondary waiting list
Frequency Percentage
High priority 177 24.8
Medium priority 414 58.0
Low priority 123 17.2
The table shows the number o f  referrals allocated to each 
priority category on the waiting list.
Of those who were offered a place on the secondary waiting list 177 (27.6 %) were given 
high priority and 414 (64.6%) were given medium priority on the list. One hundred and 
twenty-three (17.2%) were not given a priority position on the waiting list. These are 
placed in the low priority category on the list.
Table 5: Context of intervention
Frequency Percentage
Individual treatment 556 77.9
Group intervention 11 1.5
Couple therapy 2 0.3
Missing data 145 20.3
The table shows the number o f referrals allocated to each 
intervention type.
The majority, of the participants (556 (77.9%)) were offered individual follow-up treatment 
sessions. Eleven (1.5%) were offered group intervention and 2 (0.3%) were offered couple
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therapy. However, 145 (20.3%) of the data were missing for this category.
Table 6: Intervention required
Frequency Percentage
CBT nurse specialist 193 27.0
Clinical psychologist 182 25.5
Counsellor 115 16.1
Counselling psychologist 74 10.4
Clin. Psy. Or CBT 12 1.6
Clin. Psy. Or Couns. Psy. 5 0.7
Missing data 133 18.7
The table shows the number o f referrals that were 
allocated to each discipline within the service.
Following assessment referrals were also allocated to the most appropriate discipline. One 
hundred and ninety-three (27.0%) were allocated to be seen by a CBT nurse specialist. One 
hundred and eighty-two (25.5%) were allocated to a clinical psychologist, 115 (16.1%) to a 
counsellor and 74 (10.4%) to a counselling psychologist. A further 12 (1:6%) were
allocated to either a clinical psychologist or a CBT specialist, and 5 (0.7 %) were allocated , 
to either a clinical psychologist or a counselling psychologist. Missing data accounted for 
the remaining 133 (18.7 %) participants.
Forty one (5.7%) of those taken on by the service were referred to other services out-with 
the CCPS including psychiatry, practice based counsellor, addiction services, voluntary 
organisations, CMHT, rehab/neuro and learning disability services to be offered concurrent 
assessment and treatment.
DISCUSSION
Implications fo r  the service * *■
The majority of referrals are received from GP’s. This is to be expected in a primary care 
service. Other sources of referrals include hospital psychiatry and psychiatry and CPN's 
based at CMHT’s.
As described in the method section, the presenting problems that come under the anxiety 
disorder classification in DSM-IV were combined, as were those which were mood 
disorders. As a result of this, these two categories represent the majority of patients 
referred (Table 2). This finding is to be expected given the current prevalence rates of 
these disorders in the primary care setting (Nisenson et al., 1998; Coyne et al., 1994; Espie 
and White, 1986b). Other presenting problems for which there are frequent referrals 
include anger management and stress adjustment.
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CCPS aims to see all referrals for initial assessment within nine weeks of referral. The 
average waiting time of 10.39 weeks indicates that this target is almost being met. 
However, to establish the real effect of the triage system on waiting time it would be 
necessary to examine the time between triage appointment and first treatment session. 
Unfortunately, this is beyond the scope of this study.
Seventy three participants were discharged from the CCPS following their initial 
assessment (Table 3). Fourteen of these reported that their problem had been resolved prior 
to their attendance at CCPS. Thus some sources of resolution may occur while the person 
is awaiting clinical contact. Although CCPS is almost meeting their target waiting time, 
some patients are still waiting considerably longer and their difficulties may be resolved 
during this period. Thirty patients felt one session was sufficient. In these eases, it is 
possible that acknowledgement/normalisation of their problems or self-help information 
was sufficient for them to resolve their difficulties.
CCPS has introduced a prioritisation scheme that allocates patients to high priority, 
medium priority or low priority depending on the severity of the disorder. Although there 
are currently no target maximum waiting times by priority, medium priority cases are 
automatically moved to high priority after eight weeks on the secondary waiting list. Those 
in the low priority list remain there until they are seen. Therefore, it is possible that they 
will wait a considerable time for a treatment appointment.
Seventy eight percent of those referred were offered individual treatment compared to only 
0.3% who were offered a group intervention (Table 5). However, 20% of the data were
missing from this variable making these data difficult to interpret. It is possible that for 
some of those offered individual treatment, a group would be suitable, however, this is 
currently unavailable. Groups have been shown to be effective for a number of disorders, 
for example anxiety disorders (White et al., 1992).
Clinical psychologists and CBT nurse specialists are allocated the most referrals following 
the initial assessment, with CBT nurse specialists receiving slightly more than clinical 
psychologists. This has considerable implications for clinical psychology. As previously 
discussed clinical psychologists are able to work at all three skill levels (Management 
Advisory service, 1989) and so are able to treat patients who require different levels of 
skill. The allocations made to each discipline following initial assessment are 
recommendations and as such do not exclude clinical psychologists from taking patients 
from another disciplines waiting list if time is available. Therefore, the allocations do not 
imply the caseload of each discipline. However, allocation to any particular discipline does 
give an indication of the perception of the skill level required for the patients referred to 
CCPS. These results imply that most patients fall into the skill level 2 category and as a 
result this does have implications for employment of staff and cost-efficiency.
Patients’ non-attendance of appointments results in clinicians time being wasted 
(McPherson et al., 1996; Madden and Hinks, 1987). In the current climate where there is 
continual pressure to reduce waiting lists wasted sessions are an important consideration. 
High DNA rates can also lower the morale of clinicians (Startup, 1994). The new triage 
system has included an opt-in system in an attempt to reduce the first appointment DNA 
rate. However, this has not been included in the database and so it is not possible to
16
measure the success of this initiative. There is also no information on the DNA rate once 
treatment has started. An estimate of wasted time would allow an estimate of the cost 
effectiveness of the department (McPherson et al., 1996).
Limitations o f the study
Clinical audit is a requirement not only by request of the Division of Clinical Psychology 
(Cape, 1995), but also of the NHS Executive (DoH, 1989). Therefore, it should be given 
time and consideration. Guidelines for the development of audit systems have been 
proposed by a number of people. Crombie et al., (1993) and the SCPME (Marinker, 1990) 
propose a similar audit cycle which includes selecting a topic, setting standards, measuring 
practice against standards, implementing change and review.
•  k
CCPS has begun this process by selecting a topic and setting standards. However, the 
database does not adequately answer whether practice, in this particular service, meets all 
the standards set and it could be extended to examine other areas. CCPS has set standards 
regarding length of time from referral to triage assessment appointment. However, this 
does not indicate if patients are waiting less time until treatment than prior to the triage 
system. Consideration to the time between triage appointment and first treatment 
appointment is required.
One of the aims of the triage system was to reduce the first appointment DNA rate using an 
opt-in system. It was hope that this would impact on the waiting list. However, the success 
of this initiative is unclear as this information is not collected on the database. This 
information could be useful in establishing whether practice meets the standards set.
The audit was also limited by large quantities of data that were missing from the database. 
For example, 20% of the data allocating those referred to individual or group interventions 
was missing. This limits the usefulness of conclusions that can be drawn from some areas 
of the study.
CONCLUSIONS
CCPS has begun to answer the NHS executive requirement to carry out clinical audit. 
However, as highlighted above, further consideration needs to be given to the DNA rate 
and waiting times from referral to treatment appointment. Without consideration of these 
areas it is difficult to evaluate the effect of the triage and opt-in systems in terms of their 
original aims of reducing waiting times and reducing DNA rates.
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SUMMARY
Life-threatening illnesses, such as cancer, may precipitate Posttraumatic Stress Disorder
(PTSD). However illnesses are different from other traumas in both immediacy and degree
of life threat, and therefore direct comparability with general theoretical models of PTSD
cannot be assumed. This paper considers a cognitive model of PTSD in relation to cancer
patients. The author proposes possible links with the concepts fear of recurrence and sense
of coherence in moderating and mediating the development and maintenance of PTSD. A
systematic review of the literature in this field is then conducted. Overall the quality of the
literature in this field was poor. However, it did suggest that PTSD in cancer survivors
does fit within the theoretical model of PTSD outlined. Little research has been carried out
examining the possible role of fear of recurrence or sense of coherence in this process. The
• *
authors suggest this as an area for future research as it has implications for early 
intervention in those diagnosed with cancer that are at increased risk of developing 
persistent PTSD.
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INTRODUCTION
Given that up to 43.4% of people with cancer experience psychological distress (Zabora et
al., 2001) gaining an understanding of psychosocial adjustment to cancer should be a
central concern of clinicians in the field (Brennan, 2001). Depression and anxiety are just
some of the types of psychological distress that can be experienced (Zabora et al., 2001).
Since the publication of the Diagnostic and Statistical manual of the American Psychiatric
Association -  Fourth Edition (APA, 1994) cancer has been recognised as a traumatic event
capable of precipitating PTSD. Studies to date report estimated rates of PTSD from 1.9%
(Green et al., 1998) to 12% (Tjemsland et al., 1998) in cancer populations. However,
cancer differs from other traumas in both immediacy and degree of life threat. It cannot,
therefore, be assumed that PTSD related to cancer fits within current models of PTSD or
•  *
that its symptom structure will be the same.
This review examines a recent model of PTSD and its theoretical links with both a belief of 
the world as comprehensible, manageable and meaningful (sense of coherence) and fear of 
cancer recurrence. The literature relating to cancer survivors fear of recurrence, sense of 
coherence and PTSD is also systematically reviewed.
A Cognitive Model o f Posttraumatic Stress Disorder
Posttraumatic Stress Disorder is commonly diagnosed following traumatic events such as 
assault, disaster and life threatening illness. Posttraumatic stress (PTS) symptoms include 
re-experiencing thoughts, images or feelings associated with the event, avoidance of stimuli 
associated with the event and increased arousal as indicated by difficulties with
25
concentration, irritability or sleep disturbance. Many people experience some of these 
symptoms immediately following a traumatic event (Ehlers and Clark, 2000), although 
most are able to recover in the subsequent few weeks and months. However, for some the 
symptoms persist beyond three months, becoming a chronic or persistent condition.
Ehlers and Clark (2000) outlined a model of persistent PTSD, which proposes that PTSD 
persists in those who process their trauma in a way that leads to “a sense of serious, current 
threat” (p.320). Ehlers and Clark’s (2000) model is considered particularly relevant to 
cancer populations due to its emphasis on cognitive theories of anxiety which suggest that 
anxiety occurs as a result of perceived impending threat. Given that cancer recurrence is a 
possibility in most cancers it is possible that those who experience cancer are likely to have 
concerns about future threat of cancer. Ehlers and Clark’s model (Ehlers and Clark, 2000) 
proposed that two key processes lead to a sense of serious, current threat. These are:
• Individual differences in the appraisal of the trauma and/or its sequelae.
• Individual differences in the nature of the memory for the event and the memory’s 
links to other autobiographical memories.
It is proposed that individuals with persistent PTSD are unable to see the trauma as a time- 
limited event and therefore, may exaggerate the possibility of further catastrophic events 
happening to them. The model also suggests that people with persistent PTSD find it 
difficult to recollect an accurate memory of the traumatic event and report a high frequency 
of involuntary intrusive memories (see Fig. 1). These involuntary memories can involve 
re-experiencing aspects of the event in a very vivid and emotional way. The individuals’
appraisals of the event will influence their memories, thus those who appraise their trauma 
negatively are more likely to remember events that confirm their appraisal. The model 
outlines that the situation is further exacerbated by attempts to control symptoms such as 
intrusive memories, using maladaptive strategies. These strategies can result in an increase 
in the posttraumatic stress symptoms experienced. For example, attempts to push all 
thoughts relating to the trauma out of mind, can result in an increase in the number of 
unwanted intrusive thoughts being experienced. The coping strategies used to control PTS 
symptoms and current threat, are likely to be influenced by prior experience and beliefs.
Although some aspects of this model still have to undergo empirical evaluation, support has 
been provided for a number of the central features. Dunmore, Clark and Ehlers (1999) 
found that negative appraisals of the trauma (e.g. I blame myself because my actions made 
things worse; I feel like other people are ashamed of me now) predict PTSD persistence. 
Foa et a l (1995) found that the extent to which an individual is able to alter their narrative 
of the event to become more organised and coherent predicts treatment outcome. Several 
of the strategies such as safety behaviours and rumination, have been shown to predict 
persistence of PTS Symptomatology (Dunmore et al., 1999), as have memory fragments 
(Murray et al., 2002). Although further evidence is required the model is consistent with 
the main clinical features of PTSD, providing a framework for understanding and treating 
PTSD.
Insert Figure 1 about here
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The Sense o f  Coherence Construct
Following a traumatic experience many people are able to adjust well and continue with 
their lives (Ehlers and Clark, 2000), often with a more positive outlook (Park and Folkman,
1997). Several authors (Antonovsky, 1979; Kobasa et al., 1982; Rosenbaum, 1990) have 
outlined models of stress resistance that aim to explain this. One such model is the sense of 
coherence construct proposed and developed by the late Aaron Antonovsky over the last 
twenty years (Antonovsky, 1979; 1987; 1991). His model highlights the inadequacies of 
viewing disease in a manner that tries to explain why people get sick (pathogenic 
orientation). At best, he feels, this orientation highlights the role of coping mechanisms as 
buffers or moderators of stressors (Antonovsky, 1993). Antonovsky proposes that given 
the level of stressors human’s experience, the mystery is that they maintain some level of 
health and survive at all.
Antonovsky outlined a model that focused on the origins of health (salutogenic orientation) 
rather than the origins of disease. This model proposes that the secret of health is “adaptive 
coping that is moderated by generalised resistance resources”. These resources include 
wealth, social support, ego strength, coping strategies, and cultural stability. They are seen 
as leading to life experiences that promote the development of a strong sense of coherence. 
He defined sense of coherence as follows:
“a global orientation that expresses the extent to which one has a pervasive, enduring 
though dynamic feeling of confidence that (1) the stimuli deriving from ones internal and 
external environments in the course of living are structured, predictable and explicable; (2) 
the resources are available to one to meet the demands posed by these stimuli; and (3) these 
demands are challenges worthy of investment and engagement” (Antonovsky 1987; p. 19).
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In other words, those with a high sense of coherence have a way of seeing the world that 
facilitates successful coping with the many complex stressors that are confronted in the 
course of living (Antonovsky, 1993). He called the three components described above, 
comprehensibility, manageability and meaningfulness and has constructed the Sense of 
Coherence Scale (SOC Scale) based on these three components. A strong sense of 
coherence is implicated in maintaining and increasing an individual’s health status, 
therefore, those with a strong sense of coherence are less likely to experience stress.
It is hypothesised that sense of coherence is a mediating and moderating factor for PTSD. 
Ehlers and Clark’s (2000) model highlights the role of individual’s prior experiences, 
beliefs and coping strategies in the development and maintenance of PTSD and, as 
described, Antonovsky encompasses these factors in his sense of coherence constluct. It is 
proposed that sense of coherence can be implicated in box 1 (Fig. 1) of Ehlers and Clark’s 
(2000) model.
Fear o f Recurrence
Fear of disease progression or recurrence is one of the main causes of anxiety and 
psychological distress in individuals who have chronic illness (Herschbach et a l , 1997). 
Following diagnosis and treatment for cancer, people often become concerned that it will 
come back. This concept has been termed ‘fear of recurrence’ and is implicated when 
considering Posttraumatic Stress Disorder in those who have experienced a life threatening 
illness, particularly cancer. Cancer survivors have to live with the fear that their disease 
could recur and possibly become unmanageable (Sanders and Kardinal, 1977). O’Neill 
suggests that most cancer survivors experience fear of recurrence at some level (1975).
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However, others have found that 50% of patients expressed complete surprise on learning 
that they had a recurrence (Chekryn, 1984). People have different responses to the thought 
of recurrence and it is possible that these responses are mediated by sense of coherence. 
Fear of recurrence is, however, also implicated in the cognitive model of PTSD proposed 
by Ehlers and Clark (2000) and may help explain why Posttraumatic Stress Disorder has 
been found in cancer survivors. Ehlers and Clark’s model is based on the premise that 
persistent PTSD results in those who process their trauma in a way that leads to a sense of 
serious, current threat. When experienced on an intense level, fear of recurrence could be 
described as a sense of serious, current threat. This will make those with fear of recurrence 
more prone to experience PTS symptoms and to develop PTSD. Fear of recurrence can 
therefore be implicated in box 2 (Fig. 1) of the cognitive model of PTSD (Ehlers and Clark, 
2000).
Having outlined the hypothesised relationship between Posttraumatic Stress Disorder, sense 
of coherence and fear of recurrence in cancer survivors, the literature relating to each of 
these concepts with regard to cancer survivors will now be reviewed.
CRITERIA FOR INCLUDING STUDIES FOR THIS REVIEW
Study Designs
Randomised trials, cohort studies, case control studies and cross-sectional studies.
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Types o f  Participant
Persons aged 18 or over, who had a primary diagnosis of adult cancer and whose disease ,
was in remission.
Types o f Studies
Criteria for selection included literature that examined a population with a primary
diagnosis of adult cancer that was in remission, which addressed any or all of the following
issues:
1. The incidence and prevalence of Posttraumatic Stress Disorder in cancer patients.
2. The incidence and prevalence of Fear of Recurrence in cancer patients.
3. The role of Sense of Coherence in the adjustment of cancer patients.
•  »
TYPES OF OUTCOME MEASURE
1. Rates of PTSD: Impact of Events Scale (IES) (Horowitz et al., 1979), PTSD Checklist- 
Civilian Version (PCL-C) (Weathers et al., 1991), Structured Clinical Interview for 
DSM-IV-non-patient version-PTSD (SCID-NPV-PTSD) (Spitzer et a l, 1990), 
Structured Clinical Interview for DSM-IV (SCID for DSM-IV) (First et al., 1995), 
Trauma Experience Questionnaire (Widows et al., 2000), Trauma History 
Questionnaire (Green, 1996); THQ), Stressful Illness Experience (SIE) scale (Green et 
al., 1998).
2. General Psychological Morbidity: Symptom Checklist-Revised (SCL-90-R) 
(Derogatis, 1977), Medical Outcomes Study-20 Items (MOS-20; (Stewart et al., 1988),
Brief Symptom Inventory (BSI) (Derogatis, 1985), Brief COPE (Carver, 1997), 
Symptom Distress Scale (Holmes, 1989), Social Constraint Questionnaire (Jacobsen et 
al., 1998), DUKE-Social Support Questionnaire (DUKE-SSQ; (Broadhead et a l , 1988), 
Coping Response Inventory (CRI) (Moos, 1993), Interpersonal Support Evaluation List 
-  Short Form (ISEL-SF) (Peirce et a l , 1996).
Level of Fear of Recurrence: Fear of Recurrence Questionnaire (Northouse, 1981), 
Mishel Uncertainty in Illness Scale (Mishel, 1981), Growth Through Uncertainty Scale 
(Mishel and Fleury, 1994).
Level of Sense of Coherence: Sense of Coherence Scale (Antonovsky, 1987).
Anxiety: Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983), 
Profile of Mood State -  Short Form (McNair et a l , 1971).
Depression: HADS (Zigmond and Snaith, 1983), Profile of Mood State -  Short Form 
(McNair et a l , 1971), Profile of Mood State (POMS) (McNair et a l , 1992), Center for 
Epidemiological Studies Depression (CES-D) (Radloff, 1977).
SEARCH STRATEGIES FOR IDENTIFICATION OF STUDIES
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Databases
MEDLINE, PsycINFO, EMBASE, CINAHL, Cochrane 
Electronic Search Strategy
1. All references to posttraumatic stress disorder, stress response syndromes, adjustment 
disorder, fear of recurrence, illness uncertainty, and sense of coherence in all databases.
2. Reference lists of studies included in the review were searched.
Contact
1. Contact with key individuals (Northouse, Herschbach, Weathers, Keane, Komblith). 
Hand Search
Psycho-oncology (1996 (5,1) -  2002 (11,1))
Journal of Psychosocial Oncology (1983 (1,1) - 2001 (19,4))
METHODS OF REVIEW
Selection o f Studies
All potential studies were reviewed by the author to determine if they fulfilled the inclusion 
criteria.
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Data Abstraction
Data were abstracted from each article relating to study design and quality, patient 
demographics and cancer status, and measurement instruments and outcomes.
Quality Assessment
Studies were graded according to their design as follows (adapted from MacMahon and 
Lip, 2002):
la Prospective, longitudinal studies with sufficient patient numbers, well-matched 
groups and well-validated measurement instruments.
Ib Prospective, longitudinal studies with low patient numbers, but with well-matched 
groups and well-validated measurement instruments.
Ha Cross-sectional studies with sufficient patient numbers, well-matched groups and 
well-validated measurement instruments.
lib Cross-sectional studies with low patient numbers, but with well-matched groups and 
well-validated measurement instruments.
Ilia Prospective, longitudinal studies with sufficient patient numbers, but poorly- 
matched groups and/or less well-validated instruments.
Illb Prospective, longitudinal studies with low patient numbers, poorly-matched groups 
and/or less well-validated instruments.
IVa Cross-sectional studies with sufficient patient numbers, but poorly-matched groups 
and/or less well-validated instruments.
IVb Cross-sectional studies with low patient numbers, poorly-matched groups and/or 
less well-validated instruments.
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Va Prospective, longitudinal studies with sufficient patient numbers, but no groups
and/or less well-validated instruments.
Vb Prospective, longitudinal studies with low patient numbers, no groups and/or less
well-validated instruments.
Via Cross-sectional studies with sufficient patient numbers, but no groups and/or less 
well-validated instruments.
VIb Cross-sectional studies with low patient numbers, no groups and/or less well- 
validated instruments.
DESCRIPTION OF POSTTRAUMATIC STRESS DISORDER STUDTES
Excluded Studies
Twenty-seven studies related to PTSD in adult cancer survivors were identified. Overall, 
16 of these studies did not meet the criteria for inclusion in this review. Fourteen studies 
were excluded as they included patients who were not disease free (Brewin et a l , 1998; 
Celia et a l , 1990; Epping-Jordan et a l , 1994; Ey et a l , 1998; Hampton and Frombach, 
2000; Kelly et a l , 1995; Khalid and Gul, 2000; Lepore and Helgeson, 1998; Manne, 1999; 
Naidich and Motta, 2000; Primo et a l , 2000; Tjemsland et a l , 1996a; b; 1998). One study 
was excluded as it included both adults and adolescents in its sample (Lesko, 1990) and one 
paper was excluded as it was narrative (Neel, 2000).
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Included Studies
Twelve studies met the inclusion criteria (Alter et al., 1996; Andrykowski and Cordova, 
1998; Andrykowski et al., 2000; Andrykowski et al., 1998; Baider and De-Nour, 1997; 
Cordova et al., 1995; Cordova et al., 2000; Green et al., 1998; Jacobsen et a l , 2002; 
Jacobsen et a l , 1998; Mundy et a l, 2000; Widows et a l, 2000).
Design
Ten studies were cross-sectional in nature (Alter et a l,  1996; Andrykowski and Cordova, 
1998; Andrykowski et a l, 1998; Baider and De-Nour, 1997; Cordova et a l, 1995; Cordova 
et a l, 2000; Green et a l, 1998; Jacobsen et a l, 1998; Mundy et a l, 2000; Widows et a l, 
2000). Two studies were prospective longitudinal in nature (Andrykowski et a l,  2000; 
Jacobsen et a l , 2002).
Setting
Eleven studies were conducted in the USA (Alter et a l, 1996; Andrykowski and Cordova, 
1998; Andrykowski et a l, 2000; Andrykowski et a l, 1998; Cordova et a l, 1995; Cordova 
et a l, 2000; Green et a l, 1998; Jacobsen et a l, 2002; Jacobsen et a l, 1998; Mundy et a l, 
2000; Widows et a l, 2000), and one in Israel (Baider and De-Nour, 1997).
Insert Table 1 about here
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REVIEW OF STUDIES OF PTSD IN CANCER SURVIVORS
An early study by Cordova et a l (1995) examined the quality of life and cancer-related 
PTSD-like symptoms in 55 breast cancer survivors. Using the symptom method of 
diagnosis, where scores of 3 or more on the PCL-C are considered a symptom and the 
DSM-IV diagnostic rule is then followed (Weathers et al., 1993), 5% of the sample met 
DSM-IV criteria for current PTSD. These findings suggest that the prevalence of PTSD in 
breast cancer survivors may exceed base rates of these symptoms in the general population 
(0.5% in males, 1.3% in females) (Helzer et a l , 1987). Increased PTSD symptoms were 
found to be associated negatively with quality of life, income and age.
Alter et a l (1996) also examined cancer-related PTSD in cancer survivors. Twfehty-seven 
patients, who were at least 3 years from diagnosis and were involved in no active treatment, 
were interviewed using an adapted version of the Structured Clinical Interview for DSM- 
III-R (Spitzer et a l , 1990). They were compared against a community-based control group. 
Four percent of the survivor group met criteria for current PTSD and 22% of the survivor ‘ 
group met criteria for lifetime PTSD. None of the control group met criteria for either type 
of PTSD. This supports Cordova et a l ’s (1995) findings that PTSD is more common in the 
cancer population than in the general population. It was noted that the symptoms described 
by adult cancer survivors were similar to those of individuals who have experienced other 
types of traumatic events. This study was conducted as part of the field trials for inclusion 
of life-threatening illness as a trauma capable of precipitating PTSD in DSM-IV (APA, 
1994).
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A study by Baider and De-Nour (1997) questioned the findings that cancer patients suffer 
from PTSD as defined by DSM-IV. Two hundred and eighty-three female patients with ' 
diagnosed early-stage breast cancer were administered the IES (Horowitz et a l , 1979). 
None of these patients were diagnosed as having PTSD although some had high scores on 
the IES. A strong relationship was found between intrusions as measured by the IES 
(Horowitz et al., 1979) and psychological distress as measured by the BSI (Derogatis, 
1985) but only a minimal relationship (R2 = 0.07) was found between avoidance and 
psychological distress. Many of the patients showed no symptoms of increased arousal as 
measured by the BSI. Thus Baider and De-Nour (1997) concluded that although cancer 
patients did use cognitive styles that are typical of PTSD, their symptoms were not fully 
typical. This is contrary to the findings of both Cordova et al. (1995) and Alter et a l 
(1996) who suggest that PTSD is a relevant diagnosis in cancer populations. ’ *
Andrykowski and Cordova (1998) examined PTSD symptoms in 82 breast cancer survivors 
who were between 6 and 72 months from treatment completion. The PCL-C (Weathers et 
al., 1991) was used to assess PTSD symptomatology. Approximately 5% of the sample 
met criteria for formal diagnosis of current cancer-related PTSD and an additional 5-15% 
reported sub-dromal levels of PTSD symptoms. Specific risk factors that were identified 
for higher PTSD symptoms by this study include less time since treatment completion, 
greater traumatic history prior to cancer (for example rape, severe motor vehicle accident, 
or violent crime), less social support and more advanced disease.
/
Andrykowski et a l (1998) conducted a study to determine the prevalence of PTSD in 82 
breast cancer survivors and to determine the sensitivity of the PCL-C as a screening
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instrument for PTSD in this population. The SCID-NP-PTSD (Spitzer et al., 1990) was 
used to determine the PCL-C’s validity in this population. Prevalence rates of 6% for 
current and 4% for lifetime PTSD were found using the SCID-NP-PTSD. The PCL-C was 
not fully accurate for the identification of PTSD as some false negatives did occur. 
However, it is important to consider that this study was conducted using telephone 
interview which may have affected the outcomes reported. They concluded that cancer 
diagnosis and treatment can precipitate PTSD and that the PCL-C is a cost-effective 
screening tool for detection of PTSD in this population.
Green et a l (1998) examined the prevalence of PTSD in 160 breast cancer survivors. All 
participants were between 4 and 12 months post-treatment. Participants were assessed 
using the SCID for DSM-III-R, the IES, the Trauma History Questionnaire (THQ) and the 
Stressful Illness Experience (SIE) scale. Acute stress disorder and PTSD were assessed 
separately and independently for cancer and non-cancer stressors. Three percent of this 
sample met stringent diagnostic criteria for cancer-related PTSD, although there was a 
much higher prevalence of PTS symptomatology reported (36%). These results are 
consistent with the findings of Alter et a l (1996) (4%) and Cordova et a l (1995) (5-10%). 
The authors suggest that the slightly higher rates of Cordova et a l (1995) may be 
attributable to the use of a self-report measure to assess PTSD which can over-estimate 
those who meet diagnostic criteria.
Jacobsen et a l (1998) used the PCL-C to assess the prevalence and correlates of PTSD 
symptoms in 43 women who: had undergone autologous bone marrow transplantation 
(ABMT) for breast cancer. Nineteen percent of this sample met DSM-IV criteria for the
current diagnosis of PTSD. Those with longer hospital stays, more advanced disease when 
their transplant occurred and who were less well educated, reported more PTSD symptoms. 
These prevalence rates are higher than those previously reported by other authors. 
Jacobsen et a l suggest that this may be due to the women in this study having under-gone 
ABMT which has a higher mortality rate than standard treatments and has side effects that 
may be perceived as more aversive than other treatments. The women in this study also 
had more advanced disease and were a younger cohort than previous studies. Both these 
factors have previously been shown to be associated with increased PTSD symptomatology 
(Andrykowski and Cordova, 1998; Cordova et a l , 1995).
A subsequent study by the same group (Widows et a l , 2000) examined 23 male and 79 
female bone marrow transplant survivors. The PCL-C and the Structured” Clinical 
Interview for DSM-IV disorders Non-Patient Version (SCID-I/NP) (First et a l , 1995) were 
used to assess PTSD symptomatology. Five percent of this group met DSM-IV criteria for 
current PTSD. Greater PTSD symptoms were associated with more negative appraisals of 
the treatment experience, greater use of avoidance-based coping strategies, lower levels of 
social support and greater inhibition in discussing experiences. The discrepancy in the 
prevalence rates reported by the two studies was explained by improvements in supportive 
care and more effective drugs for the control of side effects.
Andrykowski et a l (2000) examined the stability of posttraumatic stress symptoms in 46 
breast cancer survivors. All participants had completed treatment and had been in 
remission for between 3-60 months. An initial telephone interview was conducted using 
the PCL-C and the Duke-SSQ. This was followed up one year later with a similar
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telephone interview. Results suggest no general diminishing of PTS symptomatology over 
time when the whole group is considered. However, examination of the individual scores 
showed fluctuations did occur with both increases and decreases in PCL-C scores being 
observed. The authors propose that this could indicate delayed onset PTSD or a waxing 
and waning symptoms course of PTSD.
A further study by Cordova et al. (2000) looked at the symptom structure of PTSD in 
cancer survivors. One hundred and forty-two breast cancer survivors were assessed using 
the PCL-C. Confirmatory factor analysis was applied to the data to evaluate the extent to 
which the symptoms reported were replicated in the symptom structure implied by DSM- 
IV. A moderate fit was found providing support for the DSM-IV clustering of PTSD 
symptoms i.e. re-experiencing, avoidance/numbing and arousal symptoms, and for the 
validity of cancer-related PTSD. This provides evidence contrary to Baider et al. (1997) 
who suggested PTSD was not an appropriate diagnosis in this population.
Jacobsen et al. (2002) conducted a longitudinal study looking at prevalence and predictors 
of PTSD in 70 bone marrow transplant recipients. The PCL-C was used to assess PTSD 
symptoms and 9% of the sample met DSM-IV criteria for cancer-related PTSD. Medical 
and demographic variables showed no significant relationship with PTSD symptomatology. 
However, avoidance-coping strategies and social support were found to account for at least 
14% of the variability in PTSD symptom severity. As a result of the longitudinal nature of 
the study, the authors suggest that these findings support the view that avoidance-coping 
and social support, play a causal role in the development of PTSD in cancer patients. This 
study corroborates the findings of previous authors (Cordova et al., 1995; Green et al.,
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1998) regarding the prevalence of PTSD in bone marrow transplant patients. However, the 
findings regarding the relationship between demographic variables, such as age and 
education, and PTSD severity, are contrary to other authors (Cordova et al., 1995; Jacobsen 
et a l, 1998; Tjemsland et al., 1998). This may be a result of lack of power due to the low 
participant numbers with respect to the use of multiple regression to analyse the data. This 
study has, however, taken an important step, going beyond cross-sectional studies of 
prevalence, to consider predictors of cancer-related PTSD.
Mundy et a l (2000) examined the prevalence of PTSD in two groups of breast cancer 
survivors. The first group had undergone ABMT and the second group had received 
conventional treatments such as surgery, chemotherapy and/or radiotherapy. None of the 
BMT group developed PTSD as a result of their treatment experience. No current PTSD 
was found in either group. This differs from findings of other authors (Cordova et a l, 
1995; Green et al., 1998) and may be a result of the small sample size in this study.
These studies suggest that some cancer patients do experience symptoms that meet the 
criteria for DSM-IV diagnosis of PTSD. They also highlight that a large number of 
patients who do not meet the diagnostic criteria for PTSD suffer sub-dromal levels o f PTS , 
symptomatology and therefore experience psychological distress as a result of their cancer 
experience. Shorter time since treatment completion, greater traumatic history prior to 
cancer, less social support, younger age and more advanced disease are all factors that have 
been associated with increased PTSD symptomatology (Andrykowski and Cordova, 1998; , 
Cordova et al., 1995). Generalisations should be cautious as the majority of these studies 
have been carried out on breast cancer patients and thus the majority of the sample
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populations are female. Many of the studies have also been carried out by telephone 
interview or using self-report measures which may reduce the reliability of their results. 
Further studies which address some of these issues are required.
DESCRIPTION OF FEAR OF RECURRENCE STUDIES
Excluded Studies
Thirteen studies were retrieved relating to fear of recurrence in adult cancer survivors. 
However, 11 did not meet criteria for inclusion in this review. Six of the studies were 
excluded due to the use of an un-standardised assessment of fear of recurrence (Fredette, 
1995; Kiebert et al., 1993; Lasry and Margolese, 1992; Noguchi et a l , 1993; Tho'ihas et al., 
1997; Vickberg, 2001). Three studies were excluded as they were narrative or case-studies 
(Aufdenkamp, 1997; Hurt et al., 1994; O'Neill, 1975) and 2 studies were excluded as they 
included patients who were not free from disease or because their criteria were not clearly 
reported in their study (Herschbach et a l , 2000; Hilton, 1989).
Included Studies
As can be seen the quality of studies in this area was poor in main due to a paucity of 
standardised measures of this construct. There were only two studies that met the quality 
standards of this review (Mast, 1998; Northouse, 1981).
Design
Both studies were cross-sectional.
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Setting
Both studies were conducted in the USA.
Insert Table 2 about here
STUDIES OF FEAR OF RECURRENCE AND CANCER SURVIVORS
Fear of cancer recurrence has been highlighted within the cancer literature on numerous
•  »
occasions (Hilton, 1989; Hurt et al., 1994; Lee-Jones et a l, 1997; O'Neill, 1975). 
However, very little research has been carried out in this area. Most of the published 
information is based on expert opinion rather than empirical evidence. No study to date has 
examined the prevalence of significant levels of fear of recurrence, although one author has 
suggested it is almost universally present at some level (O'Neill, 1975).
Empirically based studies have examined factors that mediate fear of recurrence and its 
possible role in the psychological distress experienced by cancer patients and cancer 
survivors (see Table 2). Northouse (1981) conducted a study examining the relationship 
between significant others and levels of fear of recurrence in 30 mastectomy patients who 
were in cancer remission. Significant others were defined as those to whom the subject 
could speak about mastectomy-related concerns. The Fear of Recurrence Questionnaire
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was designed and standardised as part of this study. There was a strong negative 
relationship between the number of significant others a patient had and their level of fear of 
recurrence. However, this study had a small sample size and only included female patients 
so the results should be considered with caution when considering a general cancer 
population.
Mast (1998) conducted a study of 109 breast cancer survivors who were 1-6 years post­
treatment. Data were gathered regarding symptom distress (Symptom Distress Scale; 
SDS), fear of recurrence (Fear of Recurrence questionnaire; FRQ), illness uncertainty 
(Mishels Uncertainty Illness Scale; MUIS), positive appraisal (Growth Through 
Uncertainty Scale; GTUS) and emotional distress (Profile of Mood Stated-Short Form; 
POMS). Older women were found to experience less fear of recurrence thaif younger 
women. Fear of recurrence was found to be linked to emotional distress in some women.
These studies suggest that fear of recurrence can result in considerable emotional distress. 
To date mediators of fear of recurrence have been identified as age and number of 
significant others in the patient’s life. Both these studies consider female only populations 
and therefore generalisations must be cautious (Mast, 1998; Northouse, 1981).
DESCRIPTION OF SENSE OF COHERENCE STUDIES
Excluded Studies
Twelve studies were retrieved that related to sense of coherence in cancer survivors. 
However, seven of these studies did not meet the criteria for inclusion in this study. Two 
studies were excluded as they considered patients who were newly diagnosed or who were 
still receiving treatment (Mullen et al., 1993; Ramfelt et al., 2000). Three studies were 
excluded as some participants were unclear about their diagnosis (Forsberg and Bjorvell, 
1996; Forsberg et al., 1996; 1997). One study was excluded as it was unclear whether all 
patients in the study were cancer patients (Nordstrom and Lutzen, 1995). One study was 
excluded as it was unclear whether all patients were in remission at the end of the study 
therefore could be considered survivors (Persson et a l, 2001).
Included Studies
Five studies met the quality criteria for inclusion in this study (Boman et al., 1999; Gritz et 
al., 1990; Persson et al., 1997; Wettergren et a l, 1997; Wettergren et al., 1999).
Design
Three of the studies were prospective longitudinal studies (Boman et al., 1999; Wettergren 
et al., 1997; Wettergren et al., 1999) and two studies were cross-sectional (Gritz et al., 
1990; Persson et al., 1997).
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Setting
Four studies were conducted in Sweden (Boman et al., 1999; Persson et al., 1997; 
Wettergren et al., 1997; Wettergren et al., 1999) and one study (Gritz et al., 1990) was 
conducted in the USA.
STUDIES OF SENSE OF COHERENCE AND CANCER SURVIVORS
Few studies have considered the role of sense of coherence in the psychosocial adjustment 
of cancer patients and only five studies met the inclusion criteria of this review (Table 3). 
Gritz et al. (1990) reported a study of 34 testicular cancer survivors and their spouses, who 
were screened using the Profile of Mood States (POMS), the CES-D, the Sense of 
Coherence Scale and Family Environment Scale. Both patients and spouses Kdd similar 
levels of mood disturbance as measured by the POMS and CES-D. There was a 
statistically significant negative correlation between these scores and both the patients and 
the spouses scores on the SOC scales.
Perssons et al. (1997) studied 54 survivors of acute leukaemia or highly malignant 
lymphoma. Each participant completed a qualitative questionnaire and the Sense of 
Coherence scale. SOC was found to have no relationship to the degree of problems or the 
view of care received during the treatment phase. There was however a statistically 
significant negative correlation between SOC and existential problems such as worry about 
recurrence, worry about the future and anxiety, sensitivity to infections and the need for 
counselling.
Wettergren et a l (1997) carried out a prospective longitudinal study examining 12 
participants who had undergone autologous bone marrow transplantation. They were 
assessed pre-transplant, 2-6 months post-transplant and 8-12 months post-transplant using 
the EORTC Quality of Life Questionnaire (QLQ-C30), the Hospital Anxiety and 
Depression (HAD) scale and the Sense of Coherence (SOC) scale. SOC scale scores and 
the EORTC QLQ-C30 scores were not statistically significantly related except for fatigue 
and appetite loss pre-treatment. There was no statistically significant relationship found 
between SOC scale scores and the scores on the HADS. This differs from Gritz et a l 's 
(1990) finding of a relationship between mood and SOC. It is possible that this study has 
failed to find a relationship due to the small study numbers and resulting lack of power.
Boman et a l (1999) examined two models of care in women who had completed treatment 
for breast cancer. Their perceived well-being was determined using a “study-specific 
questionnaire” and the sense of coherence scale. Group 1 received established care and 
Group 2 received continuity care. The SOC Scale scores of those in Group 2 were 
significantly higher than the scores of those in Group 1. Pre-treatment, those with a higher 
SOC had more trust in their surgeon and greater perceived general health. Those who were 
in Group 2 had better mental well-being one year after surgery compared with those in 
Group 1. The authors comment that it is possible this result was mediated by Group 2 
having a higher SOC.
A recent study by Wettergren et a l  (1999) examined the role of sense of coherence in 
cancer patients with PTS symptomatology. No statistically significant relationship was 
found between sense of coherence and PTS symptomatology, but the results were in the
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direction that suggested that those with a high sense of coherence are likely to have fewer 
PTS symptoms as compared with those who have a low sense of coherence. The authors 
comment that the failure to find a statistically significant result may be due to the small 
sample size.
These studies suggest that sense of coherence may have a mediating and moderating role in 
the psychological distress experienced by cancer patients. Many of the studies carried out 
in this area have however had small sample sizes and further research on bigger patient 
samples is needed.
CONCLUSION
•  *
Overall the quality of the literature in this area was poor, with the majority of studies 
receiving a Via rating on the quality criteria. Taking this into consideration these studies 
suggest that PTSD can result from the diagnosis and treatment of cancer and that the 
symptom structure of this disorder is similar in cancer survivors as it is in those who have 
other traumatic experiences. There is therefore no reason for future studies not to examine 
PTSD resulting from cancer within the general theoretical models of PTSD. This review 
also highlights that fear of recurrence is a recognised concept within cancer populations but 
that to date few stringent studies have been carried out to measure its psychological impact 
in cancer survivors. No studies as yet have examined the relationship between fear of 
recurrence and PTS symptomatology in cancer survivors in spite of clear theoretical links. 
Sense of coherence has been shown to mediate and moderate psychological distress in
cancer patients, particularly in relation to mood and emotional well-being. A preliminary 
study has been carried out examining the relationship between PTS symptomatology and 
sense of coherence but due to small sample size it was not conclusive (Wettergren et al.,
1999).
Given Ehlers and Clarks (2000) model of PTSD, and the literature reviewed in the current 
paper, it is possible that a link exists between PTS symptomatology caused by cancer and 
both fear of recurrence and sense of coherence. If this were the case, assessment of fear of 
recurrence and sense of coherence could allow for early intervention with those who are 
diagnosed with cancer and are at risk of development of PTS symptomatology. However, 
this relationship has not yet been empirically examined. Further work in this area may have 
implications for prevention of PTSD in response to cancer.
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CHAPTER 3 
MAJOR RESEARCH PROJECT PROPOSAL
Fear of Recurrence, Sense of Coherence and Posttraumatic Stress Disorder in
Haematological Cancer Survivors.
Esther K. Black
University o f Glasgow 
Department o f  Psychological Medicine 
Gartnavel Royal Hospital, Glasgow, G12 OXH, UK.
Prepared in accordance with the guidelines (Appendix 3.01)
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SUMMARY
Given the incidence of psychological distress found among people with cancer (Zabora et 
al., 2001) gaining an understanding of psychosocial adjustment to cancer should be a 
central concern of clinicians working in this field (Brennan, 2001). In patients with 
haematological cancer, treatment procedures are particularly intensive and can result in 
prolonged distress even after completion of treatment (McQuellon et al., 1998). In acute 
leukaemia patients high levels of distress have been found up to and more than one year 
after treatment (Lesko, 1990).
Since the modification of DSM-III to DSM-IV (APA, 1994) cancer has been recognised as 
a traumatic event capable of precipitating posttraumatic stress disorder (PTSD). Fear of 
recurrence has been recognised as a concept within cancer literature over the last twenty- 
five years (Metzger et al., 1983; Weed and Holland, 1977). Current literature suggests that 
PTSD only occurs in individuals if they process their traumatic event in a way that 
produces a sense of serious current threat (Ehlers and Clark, 2000). This suggests that 
those cancer survivors with a high fear of recurrence will also exhibit high posttraumatic 
stress symptomatology (PTSS).
However, leukaemia survivors do not all experience the same levels of distress. 
Antonovsky (1979; 1987) has outlined a construct called sense of coherence (SOC) that 
explains why some people adapt well in situations that result in psychological morbidity 
for others. This paper will therefore provide further understanding of the process of 
adjustment by examining the relationship between PTSS, fear of recurrence, and sense of 
coherence in leukaemia survivors.
INTRODUCTION
The modification of DSM-III to DSM-IV (APA, 1994) allowed the inclusion o f life- 
threatening illness, including cancer, as an event capable of precipitating PTSD. A typical 
response to cancer diagnosis and treatment includes feelings of fear, horror and 
helplessness (Smith et a l , 1999b). Intrusive thoughts and nightmares about treatment and 
attempts to avoid reminders of both diagnosis and treatment can follow. These responses 
are typical of those experienced in PTSD. However, cancer does differ in some ways from 
other trauma. DSM-IV PTSD diagnostic criteria demand “actual or threatened death or 
serious injury” (APA, 1994). In cancer this can vary considerably both in immediacy and 
degree of life threat. The significance of the intrusive thoughts experienced by cancer 
survivors may therefore relate more to threat located in the future than in the past 
(Brennan, 2001).
Studies to date report estimated rates of PTSD from 1.9% (Green et al., 1998) to 12% 
(Tjemsland et a l, 1998) in breast cancer survivors. These rates are in-line with the rates 
reported by other high-risk populations (Tjemsland et a l, 1998). However there is also a 
growing body of research that suggests that the diagnosis and treatment of cancer may lead 
to the persistence of PTSS in many patients without necessarily leading to the full 
syndrome (Brennan, 2001; Celia et a l, 1990; Cordova et a l, 1995).
Although the cancer survivor may experience an initial sense of relief on completion of 
treatment, they often go on to have feelings of intense anxiety as a result of the reduced 
involvement of the medical team and the unpredictability that sets cancer apart from other 
illnesses (Hurt et a l, 1994). Dunkel-Schetter et a l (1992) found that fear and uncertainty 
about the future were the most commonly identified cancer-related problems in cancer
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survivors. Lee-Jones et a l (1997) propose a model of fear of recurrence that states that 
people develop a representation of their illness based on personal experiences, myths and 
the media. Consequently individuals produce very different representation of their illness, 
leading to varied responses to both cancer diagnosis and level of concern about fear of 
recurrence. Fear of recurrence is, however, thought to be almost universally present 
(O'Neill, 1975; Somerfield etal., 1999).
However, many cancer survivors can experience positive growth as they adjust to changes 
brought about by their illness (Brennan, 2001). Antonovsky (1979; 1987) proposed a 
salutogenic orientation asserting that the secret of health is adaptive coping, moderated by 
‘generalised resistance resources’. These resources include wealth, social support, ego 
strength and coping strategies and are seen as leading to life experiences that promote the 
development of a strong sense of coherence(SOC) or a way of seeing the world that 
facilitates successful coping (Antonovsky, 1993). Antonovsky implicates SOC in the 
management of everyday stressors. A strong SOC is therefore implicated in maintaining 
and increasing an individual’s health status.
A paper by Mullen et a l (1993) examined cancer patients and their spouses found that 
SOC was the only significant predictor of psychological stress. One study has considered 
the role of SOC in cancer patients with PTSS. Although no significant correlation was 
found the findings fell in the expected direction with those with a higher SOC having less 
PTSS (Wettergren et a l,  1999).
A number of models of PTSD have been presented based on cognitive, cognitive- 
behavioural and behavioural theories. Ehlers and Clark (2000) have proposed a cognitive
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model of persistent PTSD that proposes that ‘persistent PTSD occurs only if individuals 
process the traumatic event and/or its sequelae in a way that produces a sense of serious 
current threat’.
Fear of recurrence appears to fit with Ehlers and Clarks’ (2000) model in that it represents 
a belief that cancer survivors have a sense of serious current threat and a belief that their 
trauma is not time-limited. This would suggest that those who have a greater fear of 
recurrence are more likely to suffer PTSS. Antonovsky’s model further adds to this 
proposing that those who have a high SOC are less likely to have fear of recurrence and are 
likely to have less PTSS. This can be concluded, as based on Antonovsky’s model, their 
SOC will provide them with adaptive coping strategies that will allow them to manage this 
stressful event.
• *
In this study those surviving haematological malignancies will be considered. These 
individuals often undergo very intensive therapy, including high dose chemotherapy, total 
body irradiation and autologous stem cell transplantation (Wettergren et a l, 1999). Such 
intensive therapy is often associated with psychological morbidity both during treatment 
and after completion of treatment (Lesko, 1990; McQuellon et a l, 1998). Very few studies 
to date have examined issue’s relating to PTSS in this population.
AIMS AND HYPOTHESES
Aims
To investigate the relationship between fear of cancer recurrence and the degree of PTSS 
experienced by cancer survivors, and to explore the role sense of coherence plays in this
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relationship. A secondary aim of the study will be the translation and standardisation of 
the Fear of Progression Questionnaire from German into English.
Hypotheses
1) It is therefore hypothesised that those who have a high fear of recurrence will have 
higher PTSS.
2) Those with a high SOC will show fewer PTSS.
3) Those with high SOC will show lower fear of recurrence.
METHOD AND DESIGN
Participants • *
Participants will be recruited from post-treatment outpatient follow-up clinics in Glasgow 
Royal Infirmary; Western Infirmary, Glasgow; and Crosshouse Hospital, Kilmarnock.
Participants will be adults (aged 18+), who are leukaemia survivors receiving no active 
treatment and attending a follow-up clinic. They will have been in continuous remission 
since primary completion of treatment and be at least 3 months post-completion of 
treatment. Worden and Weisman (1977) found that cancer patients’ distress does not peak 
until 2 to 3 months following completion of treatment. Exclusion criteria will include a 
history of chronic illness and previous experience of life threatening accidents. Patients 
who have a prior history of traumatic occurrences may have had existing posttraumatic 
symptomatology prior to their cancer diagnosis and treatment. History of previous 
psychological disorder is a predictor for PTSD, therefore those with a prior history of 
psychological disorder will be excluded from the study.
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Measures
Posttraumatic stress disorder
A number of scales have been produced for assessment of PTSD and its symptoms. Due to 
the time factor involved structured clinical assessments (e.g. the Structured Clinical 
Interview for DSM-IV) (First et al., 1995), will not be considered for this study. Brief 
symptom inventories include the Impact of Events Scale (Horowitz et al., 1979), and the 
Brief Symptom Inventory (Derogatis, 1985). These have been excluded due to a number 
of reasons including their exclusive focus on a specific type of stressor and/or their failure 
to assess the full range of PTSD symptoms.
• *
PTSS will therefore be measured using two checklists, the PTSD Checklist-Civilian 
Version (PCL-C) (Weathers et al., 1991) which has been used extensively on cancer 
populations and the Impact of Events Scale-Revised (Weiss and Marmar, 1997). The 
PTSD Checklist-Civilian Version (Appendix 3.02) is a brief 17-item inventory of PTSD- 
like symptomatology. This checklist has been designed specifically to assess traumatic 
experiences encountered in the course of everyday living. The PCL-C provides a 
continuous score (17-85) based on the quantity and severity of symptoms. This allows it to 
assess gradations in PTSD symptomatology. Reliability for this scale has been indicated 
by Cronbach’s Alpha coefficients ranging from 0.89 (Smith et al., 1999a) to 0.97 
(Weathers et al., 1993). Convergent validity has been shown by a strong correlation 
between the PCL and the Mississippi scale (0.93) (Keane et al., 1988) and the Impact of 
Events Scale (0.90) (Weathers et al., 1993). For the purposes of this study the words ‘a 
stressful experience’ on the questionnaire, have been changed to ‘your cancer experience’
to increase the ease with which the questionnaire is understood and filled out. This 
alteration in wording is within the guidelines of the author.
The Impact of Events Scale-Revised (Weiss and Marmar, 1997) (Appendix 3.03) 
comprises the original 15 items from the original Impact of Events Scale (Horowitz et al., 
1979), with an additional seven items. Six of these items assess hyperarousal and one item 
parallels DSM-IV diagnostic criteria. A test-retest reliability coefficient of 0.91 has been 
reported, as have high internal consistency coefficients of the intrusion (Cronbach’s alpha 
= 0.85), avoidance (Cronbach’s alpha = 0.85) and hyperarousal (Cronbach’s alpha = 0.94) 
subscales (Weiss and Marmar, 1997). Evidence for construct validity includes strong 
correlations among the three subscale scores, ranging from 0.74 to 0.87. This scale has not 
yet been used in this population.
•  k
Fear of Recurrence
A number of scales have been developed for the measurement of fear of recurrence 
(Easterling and Leventhal, 1989; Freidenbergs et al., 1980; Greenberg et al., 1997; 
Herschbach et al., 2000; Kiebert et al., 1993; Lasry and Margolese, 1992; Northouse, 
1981). However, the majority of these scales were developed for use in America and 
require further validation and testing on British samples. It is proposed that three measures 
be used in this study. Northouse’s (1981) Fear of Recurrence Questionnaire (Appendix 
3.04) is a 22-item scale and has been shown to have reliability (Cronbach’s alpha 
coefficient of 0.92) (Hilton, 1989) and content validity (Northouse, 1981). For the 
purposes of this study the word ‘illness’ on the questionnaire, has been changed to ‘cancer’ 
to increase the ease with which the questionnaire is understood and filled out. This 
alteration in wording is within the guidelines of the author. The more recent Fear of
Relapse/Recurrence Scale (Appendix 3.05), a five-item scale devised by Komblith 
(Greenberg et a l , 1997), using a population of adult leukaemia survivors, has also been 
shown to have both reliability (Cronbach’s alpha = 0.73) and validity (Greenberg et a l , 
1997; Hill et a l , 1998). The third measure used will be the Fear of Progression 
Questionnaire (FOP-Q; Appendix 3.06) developed by Herschbach et a l (2000). This is a 
43-item scale that has an internal consistency coefficient of 0.95 and test-retest reliability 
coefficient of 0.94. Although this scale has the highest reliability of the scales reviewed 
there is little evidence of validity with only evidence that the scale does not correlate with 
measures of anxiety. It is also not currently available in English, requiring translation and 
standardisation before reliability and validity of the scale in English can be determined. 
This will be carried out as part of the study.
Sense of Coherence
The Sense of Coherence Scale (SOC-S; Appendix 3.07) will be used to assess level of 
sense of coherence (Antonovsky, 1987). This scale consists of 29-items measured on a 
seven-point scale with two anchoring phrases for each item. Measures of reliability 
indicate good internal consistency (studies report Cronbach’s alpha scores from 0.82 to
0.95), good test-retest reliability and validity (Antonovsky, 1987; Flannery et a l , 1994).
Design and Procedure
Participants will be recruited personally by the researcher from outpatient follow-up clinics 
in Glasgow Royal Infirmary and Western Infirmary, Glasgow and Crosshouse Hospital, 
Kilmarnock. The purpose of the study will be explained to the patients, they will be given 
an information sheet to read (Appendix 3.08) and asked if they have any questions. 
Following this, those who agree to participate in the study will be asked to sign a consent
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form (Appendix 3.09). Those who give consent to participate in the study will receive a 
package that contains the questionnaires, a demographic data sheet, and a stamped, 
addressed envelope. They will either be given the option to complete the questionnaires in 
the outpatient clinic and leave it there, or complete it at home and return it by mail. Should 
caseness levels of distress be found communication will be made to the consultant and GP 
and advice will be given about onward referral. Caseness level of distress will be 
determined by a total score of 50 on the PCL-C (Weathers et al., 1993).
Data analysis
Multiple regression analysis will be carried out on the data, for the following reasons. An 
ANOVA or t-test design could only have been achieved by use of the median split 
technique. This approach was discarded primarily because the dichotomising of the 
continuous variable, SOC, into high and low bivariant categories goes against the 
underlying concept of the construct (Antonovsky, 1979). Further to this, median split 
approaches result in loss of information, which underestimates the magnitude of the , 
bivariant relationship and lowers the statistical power for detecting true effects (Maxwell 
and Delaney, 1993).
P o w er  ca lcu la tio n s
Definition o f Endpoints
High fear of recurrence will predict high PTS symptomatology and high sense of 
coherence will predict low PTS symptomatology.
Fear of recurrence and sense of coherence will be correlated with the measure of PTSS. A 
simultaneous multiple regression will then be carried out to determine the relationship
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between the dependent variable, PTSS, and the explanatory variables, fear of recurrence 
and sense of coherence.
High sense of coherence will predict low fear of recurrence.
Sense of coherence will be correlated with fear of recurrence. A single linear regression 
will then be carried out to determine the relationship between the dependent variable, fear 
of recurrence and the explanatory variable, sense of coherence.
A correlation coefficient of 0.42 would be considered to be clinically significant. With 34 
subjects the study will have 80% power to detect a correlation of 0.42 at alpha 0.05 (using 
data from (Wettergren et a l , 1999). It is noted that a model derived from multiple 
regression is likely to be over optimistic with respect to the importance of each variable. 
Altman (1990) suggests that to avoid this no more than h/10 explanatory variables should 
be considered (where n is sample size). Therefore the sample size indicated in this case is 
large enough to allow the examination of both explanatory variables.
PRACTICAL APPLICATIONS
This study will increase our understanding of the psychological mechanisms of adjustment 
and the psychological stress experienced by those who undergo cancer diagnosis and 
treatment. In particular it may provide a means of identifying those who are at risk or 
vulnerable to the development of posttraumatic stress symptomatology at the time of their 
diagnosis and thus provide preventative intervention for these individuals. It will also 
provide further information and support for current theories on the mechanisms of the 
development of PTSD.
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TIMESCALE
March/April 2001: 
May 2001:
July/ August 2001: 
March 2002:
Translation of German Questionnaire 
Ethics Applications Submitted 
Begin data collection 
Complete data collection
ETHICAL APPROVAL
Ethical approval was obtained from the North Glasgow University Hospitals NHS Trust, 
West Ethics Committee (Appendix 3.10) and East Ethics Committee (Appendix 3.11), and 
Ayrshire and Arran Health Board Research Ethics Committee (Appendix 3.12).
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AMMENDMENTS TO STUDY
1. p7. In order to recruit sufficient numbers, Hodgkin’s and non-Hodgkin’s survivors 
were also recruited for the study. An amendment to the original ethics application to 
North Glasgow University Hospitals NHS Trust, West Ethics Committee was proposed 
and approved (Appendix 3.13). Approval of this amendment was not necessary for the 
other ethics committees as the applications had not been submitted at the time of the 
change in criteria, so original applications took account of this change.
2. p7. The exclusion criteria were relaxed in order to allow sufficient recruitment. 
Patients with previous psychological disorder, chronic illness and trauma history were 
all included in the study. Information regarding the presence of these factors was 
recorded along with other demographic information.
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SUMMARY
The diagnosis and treatment of cancer has been shown to precipitate Posttraumatic Stress 
Disorder (PTSD) in some cancer survivors. However few studies have considered the 
links between cancer-related PTSD and theoretical models of PTSD. This study considers 
a cognitive model of PTSD by examining the relationship between sense of coherence, and 
fear of recurrence to posttraumatic stress symptomatology (PTSS) in haematological 
cancer survivors. Thirty-five participants completed the PTSD Checklist -  Civilian 
Version (PCL-C), the Impact of Events Scale -  Revised (IES-R), the sense of coherence 
scale and three measures of fear of recurrence. Three measures of fear of recurrence were 
included as no fear of recurrence measures had previously been assessed for reliability and 
validity on British populations.
• »
Fourteen percent of the sample met DSM-IV diagnostic criteria for PTSD. A statistically 
significant relationship was found between fear of recurrence and PTSS suggesting that 
cancer-related PTSS may fit within the theoretical model of PTSD considered. 
Statistically significant relationships were also found between sense of coherence and fear 
of recurrence and PTSS, raising questions about the possibility of using this construct as a 
screening measure for vulnerability to PTSD. Further examination of factors affecting the 
onset, maintenance and treatment of PTSD in this population is required.
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INTRODUCTION
Since the publication of the Diagnostic and Statistical Manual of the American Psychiatric 
Association -  Fourth Edition (DSM-IV) (APA, 1994) cancer has been recognised as a 
traumatic event capable of precipitating Posttraumatic Stress Disorder (PTSD). Cancer 
differs from other traumas in both immediacy and degree of life threat. It therefore cannot 
be assumed that PTSD related to cancer fits within current models of PTSD, or that its 
symptom structure is the same. Studies to date report estimated rates of PTSD from 1.9% 
(Green et a l , 1998) to 12% in cancer populations (Tjemsland et al., 1998). This can be 
compared to rates of 23% in those surviving road traffic accidents (Holeva et al., 2001) 
and 16.6% in war veterans (Kusevic et a l , 1999). There is also a growing body of 
research that suggests the diagnosis and treatment of cancer may lead to the persistence of 
posttraumatic stress symptoms (PTSS) in some patients without necessarily leading to the 
full syndrome (Brennan, 2001; Celia et al., 1990; Cordova et a l , 1995).
A number of models of PTSD have been presented over the years, which are based on 
cognitive, cognitive-behavioural and behavioural theories (Foa et a l , 1989; Horowitz, 
1997; Janoff-Bulman, 1992). Ehlers and Clark (2000) have outlined a cognitive model of 
persistent PTSD that proposes that “persistent PTSD occurs only if individuals process the 
traumatic event and/or its sequelae in a way that produces a sense of serious current threat” 
(p. 320). This model differs from other models as it attempts to use cognitive theories of 
anxiety, rather than general cognitive theories, to explain the development and persistence 
of PTSD. Kangas et a l (2002) have proposed that cancer-related PTSD should be 
examined within the network model of PTSD (Brewin et a l , 1996), however, Ehlers and 
Clark’s (2000) model is considered particularly relevant to cancer populations due to its 
emphasis on cognitive theories of anxiety, which suggest that anxiety occurs as a result of
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perceived impending threat. Cancer differs from other traumas not only in that it is a more 
protracted trauma than many, but also as cancer recurrence is a real possibility. As a result 
of this cancer survivors may have a heightened sense of impending threat.
Studies have shown that although cancer survivors may experience an initial sense o f relief 
on completion of treatment, they often go on to have feelings of intense anxiety as a result 
of the unpredictability that sets cancer apart from other illnesses (Hurt et al., 1994). 
Dunkel-Schetter et al. (1992) found that fear and uncertainty about the future were the 
most commonly identified cancer-related problems in cancer survivors. Fear of recurrence 
is thought to be almost universally present (O'Neill, 1975; Somerfield et a l , 1999). Lee- 
Jones et al. (1997) propose a model of fear of recurrence that states that people develop a 
representation of their illness based on personal experiences, myths and the media. This 
leads to a very varied response to both cancer diagnosis and the level of concern atout fear 
of recurrence experienced by the individual. Fear of recurrence appears to relate to Ehlers 
and Clarks (2000) model, as it represents a perception of serious current threat and a belief 
that the trauma is not time-limited. This would suggest that those who have a greater fear 
of recurrence are more likely to suffer PTSS.
Many cancer survivors experience positive growth as they adjust to changes brought about 
by their illness, in spite of this fear of recurrence (Brennan, 2001). Antonovsky (1979; 
1987) suggested a model that focuses on the origins of health (salutogenic orientation) 
rather than disease (pathogenic orientation). This model proposes that the key to good 
health is adaptive coping that is moderated by what he refers to as ‘generalised resistance 
resources’, which include wealth, social support, ego strength and coping strategies. These 
resources are seen as leading to life experiences that promote the development of a strong
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sense of coherence (SOC) that is a way of seeing the world that facilitates successful , 
coping (Antonovsky, 1993). A strong SOC is therefore implicated in the management of 
everyday stressors to maintaining and increasing an individual’s health status.
Two studies have been found which examine SOC in cancer patients. Mullen et a l ’s 
(1993) study examined the effects of spiritual resources, family strengths and sense of 
coherence on psychological stress in cancer patients and their spouses. The study found 
that SOC was the only significant direct predictor of psychological stress. One study has 
considered the role of SOC in cancer patients with PTSS (Wettergren et a l , 1999). No 
significant result was found between SOC and severity of PTSS. The authors highlight 
small study numbers and resulting lack of power as possible reasons for this result. These 
studies suggest that SOC may be a relevant mediator and moderator of stress in cancer
•  k
patients but further examination is required.
In summary, Ehlers and Clarks model of PTSD (Ehlers and Clark, 2000) appears to apply 
to PTSD in cancer patients as it proposes that PTSD only occurs if the individual processes 
the trauma in a way that leads to a sense of serious current threat. Cancer recurrence could 
be perceived as an immediate threat and therefore, fear of recurrence could be described as 
a sense of serious current threat. The sense of coherence construct appears to provide an 
explanation for why, in spite of there being the possibility of recurrence in most cancer, 
some cancer patients do not develop PTSS.
This study will investigate the relationship between fear of cancer recurrence and the 
degree of PTSS experienced by haematological cancer survivors, and will explore the role 
sense of coherence plays in this relationship. A secondary aim of the study will be the '
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translation and standardisation of the Fear of Progression Questionnaire from German into 
English.
HYPOTHESES
1) Those with a high fear of recurrence will have higher PTSS.
2) Those with a high SOC will have less PTSS.
3) Those with high SOC will have a lower fear of recurrence.
METHOD
Participants
In this study those surviving haematological malignancies will be considered. These
• *
individuals often undergo intensive therapy, including high dose chemotherapy, total body 
irradiation and autologous stem cell transplantation (Wettergren et a l , 1999). Intensive 
therapy is often associated with psychological morbidity both during and after completion 
of treatment (McQuellon et a l , 1998)] and psychological distress, as measured by the Brief 
Symptom Inventory (Derogatis, 1985), has been found in between 33% and 38% of those 
suffering from haematological cancer (Zabora et a l , 2001).
Forty-eight participants who had undergone treatment for Hodgkin’s lymphoma, non- 
Hodgkin’s lymphoma or acute leukaemia were recruited to the study. Thirty-four 
participants completed the questionnaires at home and returned them by post, 14 
completed the questionnaires while in the out-patient clinic. Five participants were 
excluded, either because they were found not to meet the inclusion criteria on interview 
with the researcher, or because their verbal reports of their difficulties and concerns did not
9correspond with their questionnaire responses thus their data were not considered reliable. 
A further eight participants did not return their questionnaires. Thirty-five participants 
were therefore included in the data analysis.
Measures
Posttraumatic stress symptomatology
1. PTSD Checklist-Civilian Version (PCL-) (Weathers et a l , 1991)
The PCL-C is a 17-item inventory of PTSD symptomatology. The PCL-C provides a 
continuous score (17-85) based on the quantity and severity of symptoms allowing it to 
assess gradations in PTSD symptomatology. Reliability for this scale has been indicated 
by Cronbach’s Alpha coefficients ranging from 0.89 (Smith et a l , 1999) to 0.97 (Weathers 
et a l , 1993). Convergent validity has been shown by a strong correlation betweetf the PCL 
and the Mississippi scale (0.93) (Keane et a l , 1988) and the Impact of Events Scale (0.90) 
(Weathers et a l , 1993). For the purposes of this study the words ‘a stressful experience’ 
on the questionnaire, was changed to ‘your cancer experience’ to aid understanding. This 
alteration is within the guidelines of the author (Weathers et a l , 1993). There are currently 
no data available on the validity of this change in wording. This scale has been used 
extensively on cancer populations.
2. The Impact of Events Scale-Revised (Weiss and Marmar, 1997)
This is a 22-item scale for which a test-retest reliability coefficient of 0.91 and high alpha 
coefficients for intrusion (Cronbach’s alpha = 0.85), avoidance (Cronbach’s alpha = 0.85) 
and hyper arousal (Cronbach’s alpha = 0.94) subscales (Weiss and Marmar, 1997) have 
been reported. Evidence for construct validity includes strong correlations among the three
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subscale scores, ranging from 0.74 to 0.87. No studies to date have been found that have 
used this scale on this population.
Fear o f Recurrence
A number of scales have been developed for the measurement of fear of recurrence 
(Easterling and Leventhal, 1989; Freidenbergs et al., 1980; Greenberg et a l , 1997; 
Herschbach et a l , 2000; Kiebert et a l , 1993; Lasry and Margolese, 1992; Northouse, 
1981). However, the majority of these scales were developed for use in America and 
require further validation and testing on British samples. It is proposed that the three 
measures with the highest reliability and validity be used in this study.
1. Fear of Recurrence Questionnaire (Northouse, 1981)
This is a 22-item scale that has been shown to have reliability (Cronbach’s alpha 
coefficient of 0.92) (Hilton, 1989) and content validity (Northouse, 1981). For the 
purposes of this study the word ‘illness’ on the questionnaire, has been changed to ‘cancer’ 
to increase the ease with which the questionnaire is understood and filed out. This 
alteration in wording was carried out following communication with the author. There are 
no validity data available for this change in wording.
2. Fear of Relapse/Recurrence Scale (Greenberg et a l , 1997)
This five-item scale devised by Komblith, using a population of adult leukaemia survivors, 
has also been shown to have both high reliability (Cronbach’s alpha = 0.73) and validity 
(Greenberg et al., 1997; Hill et a l , 1998).
3. Fear of Progression Questionnaire (FOP-Q) (Herschbach et a l , 2000)
This is a 43-item scale that contains five subscales, affective reactions, partner/family, 
occupation, loss of autonomy and coping. A Fear of Progression total score can be 
calculated by adding the scores of the affective reactions, partner/family, occupation and 
loss of autonomy subscales. Reliability scores for each subscale and the total score were 
high, with Cronbach’s alpha coefficients as follows, affective reactions alpha = 0.92, 
partner/family alpha = 0.80, occupation alpha = 0.92, loss of autonomy alpha = 0.87, 
coping alpha = 0.70 and total score alpha = 0.95. There is little evidence of validity except 
that the scale does not correlate with measures of anxiety. The scale is not currently 
available in English, therefore, as part of this study it was translated and steps taken to 
determine its reliability and validity.
• ¥
The procedure for translation of the questionnaire was as follows. The questionnaire was 
first translated into English by a native English speaker who was fluent in German. The 
English translation was then translated back into German by a native German speaker who 
was fluent in English. A third translator was then involved to remove any discrepancies 
that were found. Unfortunately, although all the translators were clinical psychologists, 
none of them worked in the oncology field. The questionnaire was therefore reviewed by 
three experts in the field. Following this, a pilot study involving five cancer patients was 
carried out to determine whether the questionnaire was easily understandable to it target 
group. This procedure was based on questionnaire translation guidelines set out by 
Bradley (1994).
Sense o f  Coherence
1. Sense of Coherence Scale (SOC-S) (Antonovsky, 1987)
This scale consists of 29 items measured on a seven-point scale with two anchoring 
phrases for each item. Measures of reliability indicate good internal consistency 
(Cronbach’s alpha scores from 0.82 to 0.95), good test-retest reliability (r=0.54 over a two 
year period) and validity (Antonovsky, 1993; Flannery et al., 1994). This scale is limited 
as it does not measure all the domains described by Antonovsky in his model (Antonovsky, 
1979). It is, however, the only scale currently available to measure this construct and 
provides an estimate of an individual’s sense of coherence.
Procedure
Participants were recruited from patients attending out-patient follow-up clinics in
• »
haematology departments in three general hospitals in the West of Scotland. Doctors 
involved in the clinics were asked to identify patients who had undergone treatment for 
first episode, adult Hodgkin’s lymphoma, non-Hodgkin’s lymphoma or acute leukaemia, 
who had completed treatment and were in complete remission at time of recruitment. 
Those who had rapidly deteriorating physical health, acute confusional state or dementia 
were excluded from the study.
Once identified these patients were approached by the author who explained the purpose 
and procedure of the study and then gained their consent. Demographic and treatment 
histories were taken. Participants were given the option to complete the questionnaires in 
the clinic or to take them home to complete before returning them by post. The 
participants were instructed to answer the questionnaires with reference to their
experiences of cancer and not to make reference to previous psychological disorder, other 
chronic illness experiences or previous trauma.
If any of the scores on the PCL-C or IES-R were above threshold for the possibility of the 
presence of a clinically significant psychological disorder then the appropriate Consultant 
was notified and recommendations for management were made. This was outlined to 
patients at the recruitment stage and was also contained in the information sheet.
RESULTS
Demographic data
The ratio of male to female participants was approximately 50:50 which allows the
• *
generalisation of the results across gender. Over two-thirds of the sample were either 
married or lived with a long-term partner suggesting they had good social support. 
Approximately one fifth of the sample had experienced previous traumatic experiences, 
such as witnessing a fatal road traffic accident or the death of a loved one. 
Approximately a quarter had suffered previous psychological disorders such as anxiety 
or depressive illness. About one third had a chronic illness prior to their cancer 
diagnosis. These included illnesses such as diabetes, heart disease and Sjogrens 
syndrome.
Insert Table 1 about here
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Descriptive statistics for all variables included in the study are displayed in Table 2. The 
results of this study show that 3% of the participants scored the minimum score on the 
fear of progression measure. As can be seen when the mean scores are compared with 
the minimum possible scores, many of the participants did not score highly on the fear of 
recurrence measures. Fourteen percent of this sample met DSM-IV diagnostic criteria 
(APA, 1994) for current PTSD. This was derived by considering a score of 3 or more on 
the PCL-C as a symptom and following the DSM-IV diagnostic criteria (Weathers et a l , 
1993). As can be seen from Table 2 many of the participants were also experiencing 
varying levels of PTSS, as indicated by the mean scores on the PCL-C.
Insert Table 2 about here
Reliability and validity o f the translated Fear o f Progression Questionnaire 
Reliability and validity statistics were carried out on the Fear of Progression 
Questionnaire. Cronbachs alpha coefficients and item-total correlation scores are 
displayed in Table 3.
Insert Table 3 about here
The Cronbach’s alpha coefficients of all the subscales, except the coping subscale, indicate 
good reliability, with all scores being greater than 0.7. This result is supported by the item- -
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total correlations, which based an item-total correlation coefficients of greater than 0.2 
(Streiner and Norman, 1989), show that all items in these subscales add to the homogeneity 
and reliability of the scale. However the reliability of the coping subscale is poor and only 
four of the nine items have item-total correlation greater than 0.2. This suggests that this 
subscale has poor reliability based on both Cronbach’s alpha and the item-total correlation 
scores. The validity of the Fear of Progression questionnaire was determined by 
correlating it with the Fear of Recurrence questionnaire (Northouse, 1981) and the Fear of 
Relapse scale (Greenberg et a l , 1997). Correlations among the scores on these three 
measures were high; fear of progression with fear of recurrence, r = 0.728, p<0.01; fear of 
progression with fear of relapse, r = 0.740, p<0.01. This indicates that the fear of 
progression questionnaire has good convergent validity.
Examination o f  hypotheses
In order to determine the relationship between PTSS and the two independent variables, 
sense of coherence and fear of recurrence, a simultaneous multiple regression was 
performed. The Fear of Progression total score was used in this analysis as it had the 
highest reliability of the three fear of recurrence measures. Table 4 displays the results of 
this analysis.
Insert Table 4 about here
As can be seen from Table 4 the regression was a good fit (Adjusted R2 = 72%) and the 
overall relationship was statistically significant (F (2, 25) = 35.391, p<0.01). Fear of 
recurrence was positively related to PTSS and sense of coherence was negatively related to
PTSS. Both showed a statistically significant relationship with PTSS as indicated by the t 
values. The association of fear of progression to PTSS appears stronger than that o f  sense 
of coherence to PTSS as indicated by fear of recurrences’ larger beta weight.
A simple linear regression was carried out between sense of coherence and fear of 
recurrence. The results of this analysis can be seen in Table 5.
Insert Table 5 about here
As can be seen from Table 5 the regression was a reasonable fit (Adjusted R2 = 31%) and
• *•
the overall relationship was statistically significant (F (1, 29) = 14.53, p<0.001). Sense of 
coherence was negatively related to fear of recurrence, suggesting that as sense of 
coherence increases, so fear of recurrence decreases.
DISCUSSION
Few studies to date have attempted to link PTSD in cancer patients with theoretical models 
of PTSD. This study set out to examine links between fear of cancer recurrence and Ehlers 
and Clark’s model of PTSD (Ehlers and Clark, 2000). The results support the hypothesis 
that those with a high fear of recurrence also have higher PTSS than those with lower 
levels of fear of recurrence. This supports the suggestion that an individual’s fear of
/
recurrence may be perceived as a ‘sense of serious current threat’, thus affecting their 
appraisals and memory of the trauma and increasing the possibility of them experiencing
PTSS. This may give us some indication of why, in spite of the different nature of cancer 
from other potential traumas, PTSD occurs in cancer patients.
The study also hypothesised that sense of coherence would have a role in mediating and 
moderating levels of fear of recurrence and PTSS. The results support these hypotheses, 
showing statistically significant relationships between a high sense of coherence and lower 
levels of fear of recurrence and PTSS. Sense of coherence may play a role in mediating 
and moderating an individual’s appraisal of their trauma. This is consistent with previous 
studies that have shown sense of coherence is a significant direct predictor of 
psychological stress (Mullen et a l , 1993) and is related to well-being in cancer patients 
(Forsberg et al., 1996). Since sense of coherence is proposed to be a stable construct 
(Antonovsky, 1979), it is possible that the sense of coherence scale could be used as a 
screening measure to highlight individuals, newly diagnosed with cancer, who may be 
vulnerable to PTSS. Future research would need to confirm the stability of sense of 
coherence, before carrying out a longitudinal study looking at its relationship to PTSS.
A secondary aim of the study was to translate and standardise the fear of progression 
questionnaire (Herschbach et al., 2000). As can be seen from the results the four anxiety 
subscales and the overall total score show good reliability and validity. However, the 
coping subscale showed poor reliability and no measure of validity was possible within the 
context of this study. This study provides preliminary data on the reliability and validity of 
this questionnaire, but further research is required before firm conclusions can be made. 
Due to the participant numbers it was not possible to carry out a principal components 
analysis on the questionnaire. Although this has already been carried out with the German 
version of the questionnaire it is necessary to revalidate the English version of the
questionnaire (Steiner and Pearlstein, 2000). Further investigation of the coping subscale 
of the questionnaire is also required due to its poor reliability. This may have been due to 
a loss of meaning during the translation process or a result of the low numbers in the study. 
This particular subscale should be reviewed before it could be considered for use in future 
research.
Previous authors have suggested that “fear of cancer recurrence is almost universally 
present” p.271 (O'Neill, 1975). The results suggest that some of the participants have low 
to moderate levels of fear of recurrence. This is consistent with previous research 
(Vickberg, 2001). However, neither this study nor Vickberg’s (2001) study have tried to 
determine what level of fear of recurrence is clinically significant. Standardisation of 
measures of fear of recurrence on British populations is a critical area of future research if 
more accurate prevalence data are to be collected and the psychosocial impact of fear of 
recurrence is to be determined.
Participants’ who had previous traumatic history, previous psychological disorder or who 
suffered from another chronic illness were included in this study. These factors may make 
the individual vulnerable to developing PTSD (MacFarlane, 1989) and those who had 
previous trauma history may have been suffering from PTSD prior to the diagnosis and 
treatment of their cancer. The participants were therefore requested to answer the 
questionnaires with reference to their cancer experience and not with reference to any 
previous experiences. Although this instruction will have reduced the effect these 
variables may have had on the results, the results must be interpreted with this limitation in 
mind given that approximately 50% of the sample population fell into at least one of 
groups described above.
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When proposing a model that hypothesises links between three variables and has more 
than one dependent variable, structured equation modelling is the most appropriate 
analysis. It allows the inclusion of more than one dependent variable which allows 
relationships to be determined taking account of all other relationships in the model. This 
analysis requires a robust theory and large sample sizes and therefore was not possible with 
these data. As preliminary support has been found for the theory, it would be beneficial to 
carryout further research with greater participant numbers to allow the use of structural 
equation modelling to investigate the relationships in this model further. This would also 
allow the examination of the differential contributions of fear of recurrence and sense of 
coherence to the variance of PTSS severity which has not been possible in the context of 
this study. If future research supports the model proposed, this will have implications for
•  k
the focus of treatment of PTSS in cancer patients. In particular it will allow determination 
of appropriate approaches to treatment of PTSD in this population.
/
This study represents an initial step toward understanding the mediators and moderators of 
PTSS and to linking general theoretical models of PTSD with PTSS in haematological 
cancer patients. Further studies are required to replicate and extend the research in this
area.
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Table 1: Sample Characteristics
Characteristic Descriptive
Statistic
Gender 
Female 
Male 
Age (mean/range)
Marital Status
Married or have a main partner 
Single
Time since diagnosis (mean/range) 
Time since treatment completion 
(mean/range)
Diagnosis
Non-Hodgkin’s
Hodgkin’s
Leukaemia
Chemotherapy
Yes
Radiotherapy
Yes
No
Bone Marrow Transplant 
Yes 
No
Previous traumatic experience 
Yes 
No
Previous psychological disorder 
Yes 
No
Previous chronic illness 
Yes 
No
n=16
n=19
51 yearsold/22-80 years old (16.23sd)
n=27
n=8
27 months/ 7-84 months (23.03 sd)
20 months/ 3-72 months (21.39 sd)
n=18
n=5
n=12
n=35
n=15
n=20
n=7
n=28
n=7
n=28
n=8
n=27
n=10
n=25
Table 2: Descriptive statistics for all variables included in analysis.
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Possible Range Sample Range Mean (Standard 
Deviation)
Fear of progression scale - 13-65 13-56 28.48 (8.16)
Affective reactions
Fear of progression scale - 7-35 7-27 13.77 (5.51)
Partnership/family
Fear of progression scale - 7-35 7-32 13.51 (7.18)
Occupation
Fear of progression scale - 7-35 7-27 12.94 (5.98)
Loss of autonomy
Fear of progression scale - 9-45 25-40 31.79 (4.10)
Coping
Fear of progression scale - 34-170 34-137 69.00 (22.96)
Total score
Fear of recurrence 22-110 34-92 67.66 (13.29)
questionnaire -  Northouse
Fear of recurrence 5-25 6-22 11.94 (3.63)
questionnaire -  Komblith
PCL-C 17-85 18-64 28.16(11.50)
IES-R -  Intrusion 0-32 0-24 5.00 (6 .88).,
IES-R -  Avoidance 0-32 0-25 5.03 (7.32)
IES-R -  Hyperarousal 0-24 0-21 3.73 (5.54)
SOC Scale 29-203 104-183 148.06 (20.23)
Table 3: Reliability data for Translated Fear of Progression Questionnaire 
subscales and total score.
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Cronbachs alpha 
coefficient
Item-total correlation: 
Range of scores
Affective reactions 0.84 0.24-0.59
Partnership/family 0.77 0.22-0.69
Occupation 0.92 0.56-0.91
Loss of autonomy 0.90 0.59-0.86
Coping 0.44 -0.03-0.44
Total score 0.94 0.07-0.75
Table 4: Regression analysis for variables predicting posttraumatic stress
symptomatology.
B Standard 
Error B
P t
Fear of Progression 0.238 0.056 0.562 4.247*
Sense of Coherence -0.183 0.063 -0.385 2.913*
F(2, 25) 35.391,
p<0.001
Adjusted R2 0.718
*p<0.01
Table 5: Regression analysis for variable predicting fear of recurrence.
B Standard p t 
Error B
Sense of coherence -0.665 0.174 -0.578 3.81*
F (1, 29) 14.53,
p<0.001
Adjusted R2 0.311
*p<0.001
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CHAPTER 5 
SINGLE SUBJECT RESEARCH STUDY
A Comparison of Guided Imagery, Attention to and Distraction From Pain in the
-  *•
Management of Chronic Pain: A Single Case Study.
Esther K. Black
Department o f Psychological Medicine 
Gartnavel Royal Hospital Glasgow, G12 OXH, UK.
Prepared in accordance with the guideline for submission to Behaviour Research and
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ABSTRACT
Cognitive coping strategies such as attention to and distraction from pain have been shown 
to have a positive effect on pain (Fernandez & Turk, 1989). The present study uses a 
single case design to investigate the effectiveness of four cognitive coping strategies; 
imagery distraction, non-imagery distraction, imagery attention and non-imagery 
attention, on reported pain sensation in a chronic back pain patient. Given that previous 
studies suggest that attentional strategies are more effective than distractional strategies for 
chronic pain (Cioffi, 1991; McCaul & Haugtvedt, 1982) and that imagery techniques have 
been shown to be effective in clinical populations (Fors & Gotestam, 2000; Syijala, 
Donaldson, Davis, Kippes, & Carr, 1995), it was hypothesised that the imagery strategies 
would be more effective than the non-imagery strategies and that the attentional strategies 
would be more effective than the distractional strategies in reducing reported pain 
sensation. The imagery distraction task was found to be the most effective strategy for 
reducing reported pain sensation, providing support for the first hypothesis but not the 
second. The author suggests that the imagery distraction task may have been more 
successful than the imagery attention task due to the length of intervention being too short. 
Neither of the non-imagery tasks produced a reduction in reported pain sensation.
Keywords: chronic pain, attention, distraction, guided imagery
